Sarepta Therapeutics (SRPT) Interest & Investment Income (2012 - 2025)
Sarepta Therapeutics' (SRPT) quarterly Interest & Investment Income came in at $271000.0 in Q3 2025, down 91.73% year-on-year from $3.3 million in Q3 2024, and up 418.82% quarter-over-quarter from -$85000.0 in Q2 2025.
Sarepta Therapeutics (SRPT) Interest & Investment Income (2012 - 2025) Analysis & Trends
Sarepta Therapeutics' Interest & Investment Income history runs 13 years deep, the most recent figure standing at $271000.0 for Q3 2025.
- On a quarterly basis, Interest & Investment Income fell 91.73% year-over-year to $271000.0 in Q3 2025; TTM through Sep 2025 was $3.1 million, a 91.46% decrease from a year earlier, with the FY2023 full-year figure at $36.3 million, up 2305.41% from the prior year.
- Interest & Investment Income grew to $271000.0 in Q3 2025 per SRPT's latest filing, from -$85000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $35.2 million in Q4 2023 and bottomed at -$1.6 million in Q1 2024.
- The 5-year median for Interest & Investment Income is $271000.0 (2025), against an average of $2.8 million.
- Across the five-year window, Interest & Investment Income jumped 4532.69% in 2022 and tumbled 229.24% in 2024, its largest moves.
- Year by year, Interest & Investment Income stood at $377000.0 in 2021, then jumped by 308.75% to $1.5 million in 2022, then soared by 2186.24% to $35.2 million in 2023, then sank by 90.7% to $3.3 million in 2024, then slumped by 91.73% to $271000.0 in 2025.
- Per Business Quant, the three latest SRPT Interest & Investment Income figures stand at $271000.0 (Q3 2025), -$85000.0 (Q2 2025), and $3.3 million (Q3 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Sarepta Therapeutics | 1.69 Bn | 1.28 Bn | 622.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 271,000.00 |
| Jun 30, 2025 | -85,000.00 |
| Sep 30, 2024 | 3.28 Mn |
| Jun 30, 2024 | -339,000.00 |
| Mar 31, 2024 | -1.61 Mn |
| Dec 31, 2023 | 35.23 Mn |
| Sep 30, 2023 | 417,000.00 |
| Jun 30, 2023 | -636,000.00 |
| Mar 31, 2023 | 1.25 Mn |
| Dec 31, 2022 | 1.54 Mn |
| Sep 30, 2022 | 4.78 Mn |
| Jun 30, 2022 | 2.41 Mn |
| Mar 31, 2022 | 173,000.00 |
| Dec 31, 2021 | 377,000.00 |
| Sep 30, 2021 | 148,000.00 |
| Jun 30, 2021 | 52,000.00 |
| Mar 31, 2021 | 59,000.00 |
| Dec 31, 2020 | 9,000.00 |
| Sep 30, 2020 | -12,000.00 |
| Jun 30, 2020 | 638,000.00 |